Back to Search
PETER AMBROSE, M.D.
M.D.
Specialist
NPI: 1922175041Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
G-21832(CA)
Research & Publications (20)
Use of a clinically derived exposure-response relationship to evaluate potential tigecycline-Enterobacteriaceae susceptibility breakpoints.
PMID 19073300·Diagn Microbiol Infect Dis·2009
8-other
Application of patient population-derived pharmacokinetic-pharmacodynamic relationships to tigecycline breakpoint determination for staphylococci and streptococci.
PMID 19150707·Diagn Microbiol Infect Dis·2009
8-other
An advanced pharmacy practice experience in sports pharmacy.
PMID 18322580·Am J Pharm Educ·2008
8-other
Use of pharmacokinetics and pharmacodynamics in a failure analysis of community-acquired pneumonia: implications for future clinical trial study design.
PMID 18986294·Clin Infect Dis·2008
6-review
Pharmacokinetics-pharmacodynamics of gatifloxacin in a lethal murine Bacillus anthracis inhalation infection model.
PMID 17875992·Antimicrob Agents Chemother·2007
7-preclinical
Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore.
PMID 17143821·Clin Infect Dis·2007
7-preclinical
Monte Carlo simulation in the evaluation of susceptibility breakpoints: predicting the future: insights from the society of infectious diseases pharmacists.
PMID 16506354·Pharmacotherapy·2006
6-review
Antimicrobial susceptibility breakpoints: PK-PD and susceptibility breakpoints.
PMID 15846151·Treat Respir Med·2005
6-review
Evaluating the accuracy of technicians and pharmacists in checking unit dose medication cassettes.
PMID 12073859·Am J Health Syst Pharm·2002
8-other
New antibiotics in pulmonary and critical care medicine: focus on advanced generation quinolones and cephalosporins.
PMID 16088715·Semin Respir Crit Care Med·2000
8-other
A long journey from minimum inhibitory concentration testing to clinically predictive breakpoints: deterministic and probabilistic approaches in deriving breakpoints.
PMID 19629383·Infection·2009
6-review
Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infection.
PMID 19451281·Antimicrob Agents Chemother·2009
2-rct
Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditis.
PMID 19635023·Clin Infect Dis·2009
4-observational
Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception.
PMID 19136673·Hum Reprod·2009
3-trial
Pharmacokinetic-pharmacodynamic modeling to support doripenem dose regimen optimization for critically ill patients.
PMID 19249182·Diagn Microbiol Infect Dis·2009
7-preclinical
Safe substitution to zidovudine among HIV-infected patients initiated on stavudine-containing highly active antiretroviral therapy from a resource-limited setting.
PMID 19328734·Int J Infect Dis·2009
8-other
Oritavancin population pharmacokinetics in healthy subjects and patients with complicated skin and skin structure infections or bacteremia.
PMID 19635952·Antimicrob Agents Chemother·2009
3-trial
Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adults.
PMID 19328861·Pulm Pharmacol Ther·2009
2-rct
Meropenem pharmacokinetics, pharmacodynamics, and Monte Carlo simulation in the neonate.
PMID 18645546·Pediatr Infect Dis J·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7777 MILLIKEN AVE STE 130
RANCHO CUCAMONGA, CA 91730 - Phone
- (909) 941-7008
Quick Facts
- NPI
- 1922175041
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile